2016 Postmortem
Related: About this forumMedicare's ability to negotiate drug prices as a group
This was taken away by W and the Repuke Congress.
I've heard very little about this from the Democrats sadly.
It's been over a decade for goodness sake so when will this be reinstated?
I know Bernie favors this.
Where does Hillary stand?
..
PatrickforO
(14,577 posts)Dems are gutless wonders when it comes to things like this, that would actually help a wide swath of the American people.
onecaliberal
(32,864 posts)Hoyt
(54,770 posts)Again, we'd be better off if Medicare did it directly, but only if the government is ready to say No to even life saving meds. My guess is, they aren't ready to that.
PoliticAverse
(26,366 posts)campaign positions) that indicated how little support it had even among Democrats.
In fact, it was one of the few things reps would consider. As I remember it, didn't Obama have to send Rahm scurrying around the senate to squash that amendment?
elleng
(130,974 posts)Fortunately, feds DO negotiate/enable negotiation for Federal Employees Health Benefits Plan. https://www.opm.gov/healthcare-insurance/healthcare/
PoliticAverse
(26,366 posts)"Allow Medicare to negotiate drug and biologic prices."
Scroll to the bottom at:
https://www.hillaryclinton.com/briefing/factsheets/2015/09/21/hillary-clinton-plan-for-lowering-prescription-drug-costs/
djean111
(14,255 posts)BernieforPres2016
(3,017 posts)From a study called "Mirror Mirror on the Wall" that is available online:
<On average, a brand-name drug that costs $83 under Medicare Part D would cost $48 under Medicaid and $46 under VHA. Medicare Part D paid $36 billion to brand-name manufacturers in 2010.[33] If Medicare Part D benefited from the same rebates over brand-name drugs as Medicaid, the program would have saved $15.2 billion a year on the price of brand-name drugs.>
There is a chart that shows the U.S. spending by far the highest amount on prescription drugs of any OECD country at just over $1000 per capita, even though the U.S. has the highest non-compliance rate for filling prescriptions (because of people who can't afford them) at 19% versus 2% to 13% for other OECD countries. This figure was 26% in the U.S. before the ACA. The average per capital expenditure on prescription for the second highest OEC country (Canada) was less than $800 and the OECD average was right at $500.